Tag: Josh Edgin

mets logo

The Mets continue to monitor the market for left-handed relievers

Leave a comment

After losing Josh Edgin to Tommy John surgery, the Mets are currently in search of a left-hander out of their bullpen. Brian Matusz of the Orioles has been mentioned as a possibility for a couple of weeks now, but the club has cast a pretty wide net.

Mark Saxon of ESPN Los Angeles reports that the Mets are keeping an eye on J.P. Howell, Paco Rodriguez, and Adam Liberatore from the Dodgers in case one of them becomes available. That’s no sure thing, as Howell is costly and he’s one of the only (healthy) locks in the Dodgers’ bullpen while Rodriguez and Liberatore still have options remaining.

Meanwhile, Adam Rubin of ESPN New York hears that New York is still intrigued by Rex Brothers from the Rockies. Brothers, who struggled to the tune of a 5.59 ERA over 74 appearances last season, was mentioned as a possible fit back when Dillon Gee was linked in trade talks with Colorado in December.

The Mets do have some internal options from the left side, but they aren’t pretty. Rule 5 pick Sean Gilmartin is still in camp, as well as non-roster invitee Scott Rice and minor leaguer Dario Alvarez. While a trade is a possibility, the Mets could see some names shake loose from other camps in the coming days.

Mets “have been scouting” Orioles lefty Brian Matusz

St. Louis Cardinals v Baltimore Orioles

Unhappy with their in-house options among left-handed relievers the Mets “have been scouting” Orioles southpaw Brian Matusz, according to Dan Martin of the New York Post.

Josh Edgin undergoing Tommy John elbow surgery leaves the Mets especially lacking in lefty reliever candidates and Matusz has fared well since shifting to the bullpen full time in 2013.

He has a 3.26 ERA in 146 career appearances as a reliever, compared to a 5.51 ERA in 68 starts, and Matusz has racked up 122 strikeouts in 116 relief innings. He’s set to make $3.2 million this season and is under team control for 2016 as well.

Josh Edgin to undergo Tommy John surgery

josh edgin getty

Some tough news here for the Mets’ bullpen …

Adam Rubin of ESPN New York reports that left-handed reliever Josh Edgin has decided to undergo Tommy John reconstructive elbow surgery. He’ll miss the entire 2015 season and probably won’t be back to 100 percent until sometime in April or May of 2016.

Edgin’s left ulnar collateral ligament is not torn, but an MRI showed it to be stretched out. A rehab program probably wasn’t going to fix that.

The 28-year-old southpaw posted a shiny 1.32 ERA, 0.92 WHIP, and 28/6 K/BB ratio in 27 1/3 innings last season for the Mets, who now have a huge hole at left-handed relief.

Mets monitoring the left-handed reliever market

Josh Edgin
1 Comment

With lefty reliever Josh Edgin dealing with elbow troubles which could result in Tommy John surgery, the Mets are keeping an eye on the market for left-handed relievers, ESPN’s Adam Rubin reports.

Rubin cites Sam Freeman of the Cardinals and Xavier Cedeno of the Nationals, both of whom are out of options with their respective teams. Freeman, 27, has a career 3.33 ERA and a 61/34 K/BB ratio over 70 1/3 innings. Cedeno, 28, has a career 5.19 ERA and a 50/22 K/BB ratio over 52 innings.

If the Mets decide to stay in-house for lefties, Scott Rice, Rule 5 pick Sean Gilmartin, Dario Alvarez, and Jack Leathersich are potential options.

Mets’ Josh Edgin weighing Tommy John surgery

mets logo

Josh Edgin, who was supposed to be the Mets’ top lefty out of the pen, had an MRI on his elbow the other day. The news could be worse, but it’s still pretty bad: his ligament is not torn, but it is “stretched out” and is considered compromised. The choice now: rehab vs. surgery, which Edgin will decide on in the coming days.

With Edgin out — and you have to figure that he’s out a good while, even if he doesn’t have surgery — the Mets’ bullpen is looking pretty thin, especially from the left side. Almost makes a fella think that they could’ve spent a few million bucks and brought in some more pitchers this past winter.